Henry Ford Health

Henry Ford Health Scholarly Commons
Pathology Articles

Pathology and Laboratory Medicine

5-1-2022

Granulomas associated with renal neoplasms: A multiinstitutional clinicopathological study of 111 cases
Ankur R. Sangoi
Fiona Maclean
Sambit Mohanty
Ondrej Hes
Reba Daniel

See next page for additional authors

Follow this and additional works at: https://scholarlycommons.henryford.com/pathology_articles

Authors
Ankur R. Sangoi, Fiona Maclean, Sambit Mohanty, Ondrej Hes, Reba Daniel, Priti Lal, Sofia Canete-Portillo,
Cristina Magi-Galluzzi, Kristine M. Cornejo, Katrina Collins, Michael Hwang, Sara M. Falzarano, Mike M.
Feely, Melad Dababneh, Lara Harik, Maria Tretiakova, Mahmut Akgul, Varsha Manucha, Emily Chan, ChiaSui Kao, Farshid Siadat, Kanika Arora, Guliz Barkan, Liang Cheng, Michelle Hirsch, Li Lei, Matthew Wasco,
Sean R. Williamson, and Andres M. Acosta

Histopathology 2022, 80, 922–927. DOI: 10.1111/his.14633

Granulomas associated with renal neoplasms: A multiinstitutional clinicopathological study of 111 cases
Ankur R Sangoi,1 Fiona Maclean,2 Sambit Mohanty,3 Ondrej Hes,4 Reba Daniel,5
Priti Lal,5 Sofia Canete-Portillo,6 Cristina Magi-Galluzzi,6 Kristine M Cornejo,7 Katrina Collins,8
Michael Hwang,8 Sara M Falzarano,9 Mike M Feely,9 Melad Dababneh,10 Lara Harik,10
Maria Tretiakova,11 Mahmut Akgul,12 Varsha Manucha,13 Emily Chan,14 Chia-Sui Kao,15
Farshid Siadat,16 Kanika Arora,17 Guliz Barkan,18 Liang Cheng,8 Michelle Hirsch,19 Li Lei,20
Matthew Wasco,21 Sean R Williamson22 & Andres M Acosta19
1

El Camino Hospital, Pathology, Mountain View, CA, USA, 2Department of Anatomic Pathology, Douglass Hanly Moir
Pathology, Sonic Healthcare, Macquarie Park, Australia, 3Department of Pathology and Laboratory Medicine, Advanced
Medical Research Institute, Bhubaneswar, India, 4Department of Pathology, Charles University Hospital and Medical
Facility Plzen, Plzen, Czech Republic, 5Department of Pathology, University of Pennsylvania, Philadelphia, PA, USA,
6
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA, 7Department of Pathology,
Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, 8Indiana University, Pathology,
Indianapolis, IN, USA, 9Department of Pathology, Immunology and Laboratory Medicine, University of Florida,
Gainesville, FL, USA, 10Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA,
11
University of Washington, Department of Laboratory Medicine and Pathology, Seattle, WA, USA, 12Department of
Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY, USA, 13Department of Pathology, University
of Mississippi Medical Center, Jackson, MS, USA, 14Department of Pathology, University of California San Francisco,
San Francisco, CA, USA, 15Stanford Medical Center, Stanford, CA, USA, 16Department of Pathology and Laboratory
Medicine, Cumming School of Medicine,University of Calgary, Calgary, AL, Canada, 17Department of Pathology, Henry
Ford Hospital, Detroit, MI, USA, 18Loyola University Healthcare Center, Department of Pathology, Maywood, IL, USA,
19
Department of Pathology, Brigham and Women’s Hospital,Harvard Medical School, Boston, MA, USA, 20Department
of Pathology and Laboratory Medicine, University of California Davis Health System, Sacramento, CA, USA, 21St
Joseph Mercy Hospital, Ann Arbor, MI, USA, and 22Department of Pathology, Cleveland Clinic, Cleveland, OH, USA
Date of submission 13 January 2022
Accepted for publication 23 February 2022
Published online Article Accepted 29 March 2022

Sangoi A R, Maclean F, Mohanty S, Hes O, Daniel R, Lal P, Canete-Portillo S, Magi-Galluzzi C, Cornejo K M,
Collins K, Hwang M, Falzarano S M, Feely M M, Dababneh M, Harik L, Tretiakova M, Akgul M, Manucha V, Chan
E, Kao C-S, Siadat F, Arora K, Barkan G, Cheng L, Hirsch M, Lei L, Wasco M, Williamson S R & Acosta A M
(2022) Histopathology 80, 922–927. https://doi.org/10.1111/his.14633

Granulomas associated with renal neoplasms: A multi-institutional clinicopathological
study of 111 cases
Aims: Formal depiction of granulomatous inflammation associated with renal neoplasms has mainly consisted of case reports. Herein, we investigate the
clinicopathological features and potential significance
of granulomas associated with renal tumours from a
large multi-institutional cohort.

Methods and results: One hundred and eleven study
cases were collected from 22 institutions, including
57 partial nephrectomies and 54 radical nephrectomies. Patient ages ranged from 27 to 85 years (average = 60.1 years; male = 61%). Renal neoplasms
included clear cell renal cell carcinoma (RCC; 86%),

Address for correspondence: Ankur R. Sangoi, El Camino Hospital, Department of Pathology, 2500 Grant Road GC33, Mountain View,
California 94040, USA. e-mail: asangoi2@yahoo.com
Ó 2022 John Wiley & Sons Ltd.

Granulomas associated with renal neoplasms

papillary RCC (8%), chromophobe RCC (3%), clear
cell papillary RCC (1%), mixed epithelial stromal
tumour (1%) and oncocytoma (1%). Granulomas
were peritumoral in 36%, intratumoral in 24%
and both in 40% of cases. Total granuloma count per
case ranged from one to 300 (median = 15)
with sizes ranging from 0.15 to 15 mm (mean =
1.9 mm). Necrotising granulomas were seen in
14% of cases. Histochemical stains for organisms
were performed on 45% of cases (all negative). Sixteen cases (14%) had a prior biopsy/procedure performed, and eight patients had neoadjuvant
immunotherapy or chemotherapy. Eleven patients
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(10%) had a confirmed diagnosis of sarcoidosis,
including five in whom sarcoidosis was diagnosed
after nephrectomy.
Conclusion: Based on this largest case-series to date,
peri /intratumoral granulomas associated with renal
neoplasms may be more common than initially perceived. The extent of granulomatous inflammation
can vary widely and may or may not have necrosis
with possible aetiologies, including prior procedure or
immunotherapy/chemotherapy. Although a clinical
association with sarcoidosis is infrequent it can still
occur, and the presence of granulomas warrants
mention in pathology reports.
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Introduction
Granulomatous reactions to malignancies, probably
as an immunological response to an antigenic trigger,
can occur in a variety of cancers, but have been
well-described in lymphomas.1 In some tumours (e.g.
seminoma), admixed granulomas are also histologically characteristic. Other tumours, such as urothelial
carcinoma, often demonstrate a granulomatous reaction after bacillus Calmette–Guerin (BCG) therapy.
Sarcoidosis is a multisystem granulomatous disorder,
usually characterized by non-necrotising granulomas,
and is typically a diagnosis of exclusion. Pulmonary
involvement by sarcoidosis is the prototypical organ
site (95%), with infrequent incidence of renal involvement (<1%).2 Thus far, formal depiction of granulomatous inflammation in association with renal
neoplasms has mainly consisted of case reports and
small series (cumulative case count of 283–15), with
limited follow-up and narrow description of other
putative aetiologies beyond sarcoidosis (e.g. prior
biopsy or immunotherapy). Herein, we investigate
detailed clinicopathological features and the potential
significance of granulomas associated with renal
tumours from a large multi-institutional cohort.

or intratumoral if they were embedded within the
neoplastic parenchyma. Biopsy cases of renal masses
containing granulomas were excluded. Clinical information relevant for the study was obtained from
review of electronic medical records and pathology
reports. Moreover, all available slides were rereviewed for documentation of histopathological features, including glass slide quantification of total
granuloma count per entire case, size of the largest
granuloma and the presence/absence of associated
necrosis. The information obtained from review of
pathology reports and medical records included: surgical procedure (partial versus radical nephrectomy),
patient age, tumour laterality, tumour stage, diagnosis, World Health Organization/International Society
of Urological Pathology (WHO/ISUP) nuclear grade,
utility of histochemical stains for organisms, prior
procedure (e.g. prior renal biopsy or stent), prior
pharmacotherapy (e.g. immunomodulators, checkpoint inhibitors, chemotherapy) or the presence of
nephroliths at the time of nephrectomy. Importantly,
cases with a known prior history of autoimmune conditions (namely sarcoidosis) were noted, as well as
clinical follow-up performed for potential subsequent
development of sarcoidosis. Data are available on
request from the authors.

Methods and Materials
A database search was performed from 22 different
institutions for cases of renal neoplasms containing
granulomas from nephrectomy specimens. The distribution of granulomas was classified as peritumoral if
they were located within 2 mm of the tumour border
Ó 2022 John Wiley & Sons Ltd, Histopathology, 80, 922–927.

Results
A total of 111 study cases were obtained from 22 different institutions, including 57 partial nephrectomies
and 54 radical nephrectomies, with slight left-sided
predominance (55%). Four nephrectomies for
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urothelial carcinoma that contained tumoral granulomas were excluded from the study due to a history of
prior BCG therapy. Patient ages ranged from 27 to
85 years (average = 60.1 years; male = 61%). Renal
neoplasms included several histological subtypes of
RCC: clear cell renal cell carcinoma (RCC; 86%), papillary RCC (8%), chromophobe RCC (3%) and clear
cell papillary RCC (1%). Other renal neoplasms
included mixed epithelial stromal tumour (1%) and
oncocytoma (1%). WHO/ISUP RCC nuclear grades
(chromophobe RCC excluded) were as follows: grades
2 (50%), 3 (36%), 1 (9%) and 4 (5%). Most RCC
cases were pathological stage pT1a (49%) followed by
pT3a (23%), pT1b (21%) and pT2 (7%). The distribution of granulomas was peritumoral in 36% of cases,
intratumoral in 24% of cases and both peri- and
intratumoral in 40% cases (Figure 1). Total granuloma count per case varied widely, ranging from
one to 300 (median = 15) with size of the largest
granuloma ranging from 0.15 to 15 mm (mean =
1.9 mm). Necrotising granulomas were seen in 14%
of cases. There was no association noted between size
or number of granulomas and presence of necrosis
(median = 16 granulomas in cases with necrosis versus median = 15 in those without; mean granuloma
size 3.2 mm in cases with necrosis versus mean

granuloma size 1.8 mm in cases without). Similarly,
there was no association between renal tumour type
and presence of necrotising granulomas (tumour
types in cases with granulomas included 11 clear cell
RCC, three papillary RCC and one clear cell papillary
RCC). Among the 11 cases with a diagnosis of sarcoidosis, the median granuloma count was 43, with
size of the largest granuloma ranging from 0.4 to
5 mm (mean = 2.4 mm); only two of these 11 cases
had granulomas with necrosis. Histochemical stains
[acid-fast bacteria (AFB) and Grocott’s methenamine
silver (GMS)] were performed on 45% of overall cases
(all negative for micro-organisms), and were performed on 67% (10 of 15) cases with necrotising
granulomas. In two cases with necrotising granulomas, polymerase chain reaction (PCR) testing for
mycobacteria was performed (negative in both cases).
None of the cases contained admixed refractile material within or adjacent to the granulomas.
Sixteen cases (14%) had pre-operative procedures
performed, including 11 cases with core biopsy, two
cases with embolisation, two cases with stent placement and one case with nephrolithotomy. Only
two cases (2%) had a nephrolith present at time of
nephrectomy. Eight patients had a history of
pre-operative
neoadjuvant
immunotherapy
or

A

B

C

D

Figure 1. A,B, Intratumoral granulomas. Numerous granulomas are present within the tumour parenchyma of this clear cell renal cell carcinoma (RCC) [A, haematoxylin and eosin (H&E)]. In this case, the granulomas are non-caseating (B, H&E). C,D, Peritumoral granulomas.
Granulomas with necrosis are present at the border between this clear cell papillary RCC and the adjacent renal parenchyma (C,D, H&E).
AFB and GMS histochemical stains were performed on this case (negative for micro-organisms). Neither of these study cases had a prior history of sarcoidosis, prior procedure or prior immunotherapy/chemotherapy.
Ó 2022 John Wiley & Sons Ltd, Histopathology, 80, 922–927.
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chemotherapy, including three targeted for renal cell
carcinoma, one for melanoma, one for lymphoma,
one for renal transplant, one for mixed connective
tissue disease and one for rheumatoid arthritis. A
total of 11 patients (10%) had a confirmed diagnosis
of sarcoidosis, consisting of six patients with a
known pre-operative diagnosis and five patients in
whom sarcoidosis was diagnosed only after nephrectomy. One patient had a known pre-operative diagnosis of mixed connective tissue disease and another
of rheumatoid arthritis. None of the patients had a
known history of vasculitis, pyelonephritis or tuberculosis. Clinical follow-up was available in 94%
of cases, with the time interval from nephrectomy
to latest clinical inquiry of putative diagnosis of sarcoidosis ranging from one to 212 months (mean =
34 months). One patient presented with concurrent
lung nodules at the time of nephrectomy (thought
to represent pulmonary metastasis from RCC),
with histological documentation of nephrectomy
granulomas leading to timely clinical diagnosis of
sarcoidosis.

Discussion
The initial depiction of a renal neoplasm with
admixed granulomas was from a 1993 case report of
a RCC with intratumoral granulomas, without a confirmed diagnosis of sarcoidosis.6 A review of previously published studies (mainly individual case
reports or small series) of granulomas in renal neoplasms also highlights this association (Table 1), with
some allusion to a sarcoidosis link but with limited
discussion of other putative aetiologies. Based on our
study, to our knowledge the largest case-series to
date, several important points emerge.
First, granulomas associated with renal neoplasms
are more often peri- than intratumoral alone (36 versus 24%) but usually show both patterns (40%), and
may be more common than initially perceived. While
the multi-institutional collaborative nature of our
study allowed for a large capture of study cases, most
individual contributors notably submitted several
cases each. Moreover, during study design several
contributors noted that they had encountered additional cases of granulomas in neoplastic RCC
nephrectomies, but because of limited pathology
report documentation these were difficult to retrieve
by electronic database review. Therefore, because
granulomas are an incidental finding in the context
of surgery performed for a renal neoplasm, they are
probably under-reported in most institutions.
Ó 2022 John Wiley & Sons Ltd, Histopathology, 80, 922–927.
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Secondly, while the majority of study cases
involved malignant tumours (98%), our study and
two others10, 15 demonstrate that benign renal neoplasms can also be associated with granulomas.
While the exact aetiology of this granulomatous
response remains unclear, one study proposed that
the high content of glycogen present in clear cell RCC
(similar to that seen in seminoma) might be an eliciting factor.3 As 86% (95 of 111) of our study cases
were clear RCC and 86% (24 of 28) of other cumulative cases were also clear cell RCC, a response to
glycogenated tumour cells may indeed be at least
responsible, in part, for the formation of the associated granulomas. Biochemically, the release of angiotensin I-converting enzyme from multinucleated giant
cells in sarcoidosis16 may also play a role in tumoral
granulomatous response, although infection, vasculitis and drug reactions may also be considered among
potential aetiologies.
While we observed more granulomas in study cases
with a diagnosis of sarcoidosis than those without
(median granuloma count = 43 versus 15), the total
granuloma count per case varied widely (range = 1–
300). As such, careful scrutiny may be needed to
identify peri- or intratumoral granulomas, which are
often small in size (mean = 1.9 mm). Care should
also be taken to avoid misclassifying a multinucleated
tumour cell, megakaryocyte or Langerhans cell (uncommon but reported in RCC17–19) as a multinucleated giant cell. In keeping with the histology of
typical sarcoidosis, necrotising granulomas were only
present in 18% (two of 11) of study cases with a
known diagnosis of sarcoidosis (overall rate of necrotising granulomas was 14%). Histochemical stains
(AFB and GMS) were performed more often on study
cases with necrotising granulomas (67 versus 45% of
overall cases), as might be expected for those found
at any other organ site. Despite all cases being negative for micro-organisms in our study, given that sarcoidosis is a diagnosis of exclusion, the use of
histochemical stains may be prudent in routine practice when encountering peri- or intratumoral renal
granulomas, especially if the granulomas are of a
necrotising nature.
Drug-induced sarcoid-like reactions have been wellrecognized as a tissue reaction to systemic therapy,20
with tumour-associated local T cell-mediated granulomatous reactions receiving more recognition with
the utility of novel immunotherapeutic agents.21 In
our series, eight patients (7%) had a history of preoperative neoadjuvant immunotherapy or chemotherapy. Of the 16 study cases (14%) with pre-operative
procedures performed (well known to elicit a tissue
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Table 1. Previously published studies of granulomas associated with renal neoplasms
Study

No. of cases

Renal tumour(s)

Renal tumour subtype(s)

Distribution of
granulomas

Sarcoidosis*

Campbell et al.

1

RCC

Clear cell RCC

Intratumoral

None

Bottone et al.

1

RCC

Clear cell RCC

Peritumoral

1/1 (100%)

Marinides et al.

1

RCC

Papillary RCC

Peritumoral

None

Hes et al.

3

RCC

Clear cell RCC

Intratumoral

None

Kovacs et al.

1

RCC

Clear cell RCC

Intratumoral/peritumoral

None

Piscioli et al

1

RCC

Clear cell RCC

Peritumoral

None

Narasimhaiah et al.

3

RCC

Clear cell RCC

Intratumoral

None

Ouellet et al.

1

RCC

Clear cell RCC

Peritumoral

None

Burhan et al.

1

RCC

Clear cell RCC

Intratumoral

None

Khatua et al.

1

RCC

Clear cell RCC

Peritumoral

None

Arora et al.

11

RCC

Clear cell RCC (n = 10),

Intratumoral/peritumoral

1/11 (11%)

Intratumoral/peritumoral

2/2 (100%)

Clear cell
papillary RCC (n = 1)
Majeed et al.

2

RCC

Clear cell RCC (n = 1),

MCNLMP

MCNLMP (n = 1)

Tarjan et al.

1

AML

AML

Unknown†

None

Current study

111

RCC, MEST,
oncocytoma

Clear cell RCC (n = 95),
papillary RCC (n = 9),

Intratumoral/peritumoral

11/111 (10%)‡

Chromophobe RCC (n = 3),
clear cell papillary RCC (n = 2),
MEST (n = 1), oncocytoma (n = 1)
AML, angiomyolipoma; MCNLMP, multilocular cystic neoplasm of low malignant potential; MEST, mixed epithelial stromal tumour; RCC,
renal cell carcinoma.
*Cases with either known history of or subsequent diagnosis of sarcoidosis;
†
Diagnosed on a core needle biopsy;
‡
Five cases were diagnosed with sarcoidosis only after nephrectomy identified granulomas.

response regardless of organ site), none (0%) were
from patients with a diagnosis of sarcoidosis. As such,
when encountering a renal neoplasm with associated
granulomas, chart review for possible prior pharmacotherapy or prior renal procedure may offer a useful
clinicopathological correlation. With nephroliths at
the time of nephrectomy identified in only 2% of
study cases, nephrolithiasis seems an unlikely contributing factor.
While only six patients had a known pre-operative
diagnosis of sarcoidosis, five cases were subsequently
diagnosed with sarcoidosis after tumoral granulomatous inflammation was identified on histological
review of the nephrectomy specimen. In these five
cases, more thorough clinical and radiographic exploration for extrarenal granulomas ultimately

confirmed a diagnosis of sarcoidosis. Our study tally
of 10% (11 of 111 patients) is in keeping with the
overall reported incidence 14% (four of 28 patients)
of sarcoidosis from previously published studies of
granulomas associated with renal neoplasms
(Table 1). Therefore, in order to alert clinicians that
additional work-up is advised for a putative diagnosis
of sarcoidosis, formal documentation of tumoral granulomas in the pathology report is crucial. This is particularly relevant in light of the finding that, in a
small subset of patients, granulomas found in the
nephrectomy specimen might be the first indication of
sarcoidosis.
Although not the focus of our study, it is worth
noting that the presence of tumoral sarcoid-like granulomas (designated an immune-mediated antitumour
Ó 2022 John Wiley & Sons Ltd, Histopathology, 80, 922–927.
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response of macrophages by activated T cell lymphocytes22) in cancer patients has been associated with
reduced metastasis and increased survival;23 however, there are limited data involving RCC patients.
Pertaining to cancer risk and sarcoidosis, it is interesting to note that from one study, the relative risk
for development of RCC by a diagnosis of sarcoidosis
is small but statistically significant (relative risk of
1.5524), making early recognition of potential sarcoidosis relevant for possible early screening. Also, it
is reasonable to speculate that, in the absence of sarcoidosis, RCCs with a granulomatous reaction might
have shared molecular features. Further genomic and
epigenomic studies including RCC with granulomas
not associated with sarcoidosis are required to explore
this hypothesis.
Based on this largest case series to date, peri- and
intratumoral granulomas associated with renal neoplasms may be more common than initially perceived, and can be seen in both benign and
malignant tumours. The extent of granulomatous
inflammation can vary widely and may or may not
have necrosis, with possible aetiology from a prior
procedure
or
immunotherapy/chemotherapy.
Although a clinical association with sarcoidosis is
infrequent, it can occur and warrants reporting of
the granulomas to ensure patients receive diagnostic
evaluation of suspected sarcoidosis.
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